Clinical trial
A Therapy for Improving Symptoms in Patients With Acute Exacerbations of Copd by an Hydrogen-Oxygen Generator With Neburlizer: A Multi-centric, Randomized, Parallel-control and Double-blinded Clinic Study
NCT04000451 is registered in ClinicalTrials.gov with Shanghai Asclepius Meditec Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Therapy for Improving Symptoms in Patients With Acute Exacerbations of Copd by an Hydrogen-Oxygen Generator With Neburlizer: A Multi-centric, Randomized, Parallel-control and Double-blinded Clinic Study
- Lead sponsor
- Shanghai Asclepius Meditec Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 7, 2019
- Completion date
- September 20, 2019
- Enrollment
- 108 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd exacerbation acute